In March 2025, the company introduced new strategies for any direct-to-customer giving of its Wegovy weight loss drug. The company recognized a fresh pharmacy, identified as NovoCare, which would demand customers $499 each month for entry to the drug, under fifty percent the cost of the drug via other pharmaceutical distribution networks.[fifty thr